| Dr Keith E Byers, MD | |
|
35040 Chardon Rd # Suite 6200, Willoughby Hills, OH 44094-9055 | |
| (440) 953-9014 | |
| (440) 953-9173 |
| Full Name | Dr Keith E Byers |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 35040 Chardon Rd # Suite 6200, Willoughby Hills, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326115528 | NPI | - | NPPES |
| 0402479 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 39718 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keith E Byers, MD 35040 Chardon Rd # Suite 6200, Willoughby Hills, OH 44094-9055 Ph: (440) 953-9014 | Dr Keith E Byers, MD 35040 Chardon Rd # Suite 6200, Willoughby Hills, OH 44094-9055 Ph: (440) 953-9014 |
News Archive
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced top-line results from the first of two planned Phase 3 clinical studies evaluating low-dose mesylate salt of paroxetine (LDMP, formerly referred to as Mesafem) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement with TG United, Inc. of Brooksville, Florida, to provide commercial-scale manufacturing capabilities for reaZin. Adeona is developing reaZin, its product candidate for the dietary management of Alzheimer's disease and mild cognitive impairment, as a prescription medical food.
Multiple Sclerosis or MS is a severely disabling disease that affects 100,000 in the UK. Now a new pill has been developed to treat multiple sclerosis which means there would be no need for injections. European health experts - European Medicines Agency (EMA) have given the new drug Gilenya, the brand name for the drug fingolimod, approval which would grant it EU wide acceptance.
A new study by researchers at Oxford University examines neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
› Verified 8 days ago
Vivian A Chukwuani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2550 Som Center Rd # Wh20, Willoughby Hills, OH 44094 Phone: 440-943-2500 Fax: 440-516-8280 | |
Dr. Gary Brian Kaplan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 35040 Charon Rd, Suite 201, Willoughby Hills, OH 44094 Phone: 440-946-0053 Fax: 440-946-1812 | |
Varinder S. Dhillon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2747 Som Center Rd, Suite D, Willoughby Hills, OH 44094 Phone: 440-516-0530 Fax: 440-516-0492 | |
Dr. Hallie Sara Kendis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 35040 Chardon Rd, Building Vii Ste 110, Willoughby Hills, OH 44094 Phone: 440-946-1200 Fax: 440-946-5186 | |
Stephanie Ribelli, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2550 Som Center Road, Wh 20, Willoughby Hills, OH 44094 Phone: 440-943-2500 | |
Dr. Ronald Purcell, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2550 Som Center Rd Ste 310, Willoughby Hills, OH 44094 Phone: 440-516-8393 |